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Abstract
Background: In the "post-genome" era, mass spectrometry (MS) has become an important
method for the analysis of proteins and the rapid advancement of this technique, in combination
with other proteomics methods, results in an increasing amount of proteome data. This data must
be archived and analysed using specialized bioinformatics tools.
Description: We herein describe "PARPs database," a data analysis and management pipeline for
liquid chromatography tandem mass spectrometry (LC-MS/MS) proteomics. PARPs database is a
web-based tool whose features include experiment annotation, protein database searching, protein
sequence management, as well as data-mining of the peptides and proteins identified.
Conclusion: Using this pipeline, we have successfully identified several interactions of biological
significance between PARP-1 and other proteins, namely RFC-1, 2, 3, 4 and 5.
Background
Proteomics aims to identify, characterize and quantify all
of the proteins expressed by a given living organism, tissue
or cell line[1]. Typically, this approach subjects protein
mixtures to proteolytic digestion prior to liquid chroma-
tographic separation and MS/MS analysis of the resulting
peptides [2]. Several database search engines, notably
Mascot[3], Sequest [4], and X!Tandem [5] assign probable
peptide sequences to MS/MS spectra and infer the identity
of the proteins present in the sample analyzed. High-
throughput proteomic experiments generate large data
sets of protein identifications, which can only be properly
validated and reported through adequate data processing
[1,6,7]. Subsequent integration, sorting and comparison
of these datasets pose significant challenges, especially
when simultaneously analysing multiple experiments.
One of the most effective approaches to elucidate the bio-
logical function of a protein is the identification of its
interaction partners. We are only now beginning to appre-
ciate the nature and complexity of networks of interacting
proteins. The unravelling of any such network using tradi-
tional biochemical approaches remains a significant chal-
lenge. Recently, however the application of high-
throughput technologies, such as large-scale yeast two-
hybrid analysis and mass spectrometry coupled to
immuno- or affinity-based capture has made possible the
rapid generation of huge protein interaction datasets [8-
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10]. As consequence, researchers often face the dilemma
of how to effectively utilize all available data. Investiga-
tors relying solely on a traditional approach to draw con-
clusions or set research priorities are likely to find
themselves outpaced by peers who combine in silico biol-
ogy and empirical methods. Thus for protein interaction
studies, there is clearly a need to develop a systematic and
stepwise in silico approach to predict potential interactors.
This approach will most likely improve our understand-
ing of how complex biological systems work.
The need to develop a Laboratory Information Manage-
ment System (LIMS) for researchers in the field of pro-
teomics that would allow to track, archive and aid in a
greater understanding of how biological systems work has
been recognized. In 2002, Cho and co-workers developed
an original LIMS for proteome research (YPRC-PDB)[11],
constructed using a commercial database (RDB). They
intended to establish YPRC-RDB as a proteome data ware-
house. In 2003, Goh and co-workers [12] developed
SPINE2, a LIMS for structural proteomics, constructed
with MySQL and Perl, and also designed to work as a pipe-
line to public data resources. In 2004, Garwood and co-
workers [13] developed PEDRo, The Proteomic Experi-
mental Data Repository, constructed with a native XML
database, Xindice with an ambitious Apache Software
Foundation basis. The XML-based document format has
been chosen for communication that the other formats.
The native XML database has great potential, but many
have critical limitations for proteomic research. On the
other hand, commercially available LIMSes (Amersham
Biosciences and Bio-Rad Laboratories Inc, etc.) have also
been developed and released, but they are not exactly suit-
able for laboratories like ours because the generic solu-
tions are first and foremost prohibitively expensive. These
systems are usually re-packagings of applications devel-
oped for the pharmaceutical industry for drug discovery
and development.
The focus of our laboratory is the study of the action of
poly(ADP-ribose) polymerases (PARPs) and their role in
the cell. Poly(ADP-ribosylation) is a post-translational
protein modification consisting of long chains of
poly(ADP-ribose) (pADPr) synthesized by PARPs at the
expenses of NAD+. Poly(ADP-ribose) chains are short-
lived owing to the activity of the poly(ADP-ribose) glyco-
hydrolase enzyme, which catabolizes the pADPr within
minutes of its synthesis[14]. The PARP family may com-
prise as many as 17 members which share a common cat-
alytic domain responsible for the synthesis of poly(ADP-
ribose) [15-17]. The best characterized and abundant
member of this family is PARP-1, a 113-kDa nuclear pro-
tein comprising a DNA-binding domain made of two zinc
fingers that allow PARP-1 to be rapidly activated in
response to DNA damage. Poly(ADP-ribose) crucially
contributes to chromatin remodelling, DNA damage
repair, regulation of transcription, and cell division [18-
20]; and PARP-1 is an important actor in many key cellu-
lar processes, including BER, transcription, and apoptosis.
We herein describe the architecture and major features of
a web-based utility called "PARPs database" (PARPs-DB),
which is designed to rationally organize the protein and
peptide data generated by the LC-MS/MS analysis of tryp-
tic digest of proteins that co-immunoprecipitate with
PARPs proteins into reports meaningful to biological
researchers. PARPs-DB offers a LIMS work environment to
annotate and study protein-protein interactions and its
easy-to-use relational data management system can rap-
idly supply information pertaining to the biological char-
acteristics of a majority of proteins in a proteomic dataset.
The major features of our LIMS are flexibility, compact-
ness, and connectivity to public databases.
Also presented is a list of previously unidentified PARP-1
interactors that were found via affinity co-immunoprecip-
itation, as well as the analysis of these new PARP-1 inter-
actions generated through PARPs-DB.
Given the advantages provided by an in silico approach
that can predict or prioritize potential interactors, it seems
reasonable to propose that PARPs-DB will become an
essential tool for initially evaluating novel hypotheses and
will offer improved rationale for the prioritization of
potential interactors. In effect, by facilitating the process-
ing of protein-protein interactions and the selection of the
most promising interactors (to be submitted first to
empirical measurements) PARPs-DB should lower the
cost and shorten the time necessary to discover the most
biologically significant interactions between PARPs and
other proteins.
We don't have infrastructure to access on-line but the
PARPs database source codes and user documentation are
available for the scientific community [21]. Tools from
the Sashimi project that were used in PARPs-DB are also
available [22]. Licensed programs in Sourceforge such as
Mascot, Sequest or Oracle were not included in the PARPs
repository. Dialects for MySQL and PostgreSQL servers
were developed in alpha version and are available upon
request. Further information on these scripts can be
obtained from the corresponding author (see Additional
file 1).
Construction and Content
Design of the PARPs database software
PARPs Database consists of a core system of services that
provide underlying system functionality. Modules, which
provide most data handling and analytical support (such
as LC-MS/MS data mining), plug into the core. This designBMC Bioinformatics 2007, 8:483 http://www.biomedcentral.com/1471-2105/8/483
Page 3 of 16
(page number not for citation purposes)
means the platform is easily expandable: the architecture
allows new analytical modules to be added and integrated
without having to modify the core system. PARPs data-
base was designed to be platform-independent and easy
to maintain, and is implemented in Solaris Sun Operating
system 10 (Sun Microsystems, Santa Clara, CA, USA). It
requires access to an Oracle 10 g relational database (Ora-
cle, Redwood Shores, CA, USA), with which it communi-
cates through an abstraction layer that isolates the core
system from subtle differences between Oracle database
builds. The user interface supports the use of the Apache
server[23] for external access via the Hyper Text Transfer
Protocol (HTTP). It consists of a set of programs, written
in the Practical Extraction and Report Language (Perl) and
in PL/SQL, which generates the user interface in Hypertext
Transfer Markup Language (HTML), using Cascading Style
Sheets (CSS), eXtensible Markup Language (XML) Style
sheet Language Transformation (XSLT), and the Scalable
Vector Graphics language (SVG). A web browser is used as
the user interface of the LIMS, because it is universally
available on most client systems. Internet Explorer 6.0 or
later, Netscape 7.1 or later, or Firefox version 1.03 or later
should be installed in the client PC.
Dialects for PostgreSQL and MySQL servers were imple-
mented, and support for Microsoft SQL is under develop-
ment.
Database design
Figure 1 outlines the database schema for the data pertain-
ing to experimental protocols, data analysis and results
(the full-scale schema is available on-line as Supplemen-
tal Figure 1). The database is defined in the Unified Mod-
eling Language [24], which is a standard notation
designed to improve the process of developing large soft-
ware systems [25]. In this context, it allows us to describe
experimental methods, results, and subsequent analyses
in an implementation-independent manner. UML sche-
mas (Figure 1) are referred to as class diagrams. They con-
sist of boxes (classes), representing important entity types,
connected by various types of lines and arrows signifying
the relationship between them.
A simplified schematic representation of the structure of PARPs database Figure 1
A simplified schematic representation of the structure of PARPs database. Different classes (rectangles) with their 
associations (lines) are shown. A class is described by its attributes, e.g. a sample can be specified by its name, date. Colours 
denote sample generation (red), sample processing (purple), mass spectrometry (orange), MS results analysis (green), and in sil-
ico MS results analysis (blue). The full-scale schema is available on-line as supplemental Figure.BMC Bioinformatics 2007, 8:483 http://www.biomedcentral.com/1471-2105/8/483
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The sample origin (shown in red) holds basic informa-
tion, such as the specific biological material used, which
subcellular fraction was studied, and the experimental
conditions to which the organism was subjected. Sample
origin has also two offsprings: 'organism' holds the name
of the species/strain used and a list of the relevant gene/
mutations carried; and 'tagging process' describes the
labelling of the parts of a combined sample for differential
expression studies, such as isotope-coded affinity tag
(ICAT) mass spectrometry[26].
The sample (shown in purple) simply holds an identifi-
cation code (laboratory-specific), the production date,
and the name of the responsible person.
The next classes represent sample's processing step before
moving on to run a mass spectrometry experiment. For
example, running a two-dimensional gel with sample,
then putting a spot from that gel through two-dimen-
sional liquid chromatography. The class HPLC describes
the equipment's origin, its dimensions, the stationary
phase, the pore size in the beads, the total injection vol-
ume, and the flow rate. The class gel capture the descrip-
tion of the gel, the image analysis software used, and
whatever images of the gel are available, referred to by
URIs (Universal Resource Identifiers). There are also sev-
eral parameters describing the gel itself (for example, per-
cent acrylamide in the mix, the solubilisation buffer and
stain used, a measure of the total protein on the gel, the
in-gel digest).
Mass spectrometry (shown in orange). Details about the
makeup of the mass spectrometry machine is stored in
seven classes. Source is an abstract class that will, in prac-
tice, be either MALDI or Electrospray, each of which has
its own set of fields (voltages of various kinds; tip, solvent,
and interface details for electrospray; laser wavelength and
matrix type for MALDI runs). Instrument represents the
mass analysing and fragmentation section of the mass
spectrometer (for example, Quadrupole, Ion Trap, or Col-
lision Cell, each with its own parameters).
MS results analysis (shown in green). To perform a pro-
tein identification, a particular Peak list would be submit-
ted to an identification tool, such as Mascot, Sequest and
X!Tandem. The classes 'DBSearch Parameters' capture
information about who processed data, when they did it,
what program they used, what database was used, what
errors were taken into account when searching, what
potential modifications were allowed on proteins from
the sample that generated the peak list.
The protein tables (shown in blue) store identifiers
(accession numbers) that point to external web-based
information sources. Short text annotations such as Gene
Ontology [27] descriptions, descriptions of functional or
structural regions within the protein sequence, and infor-
mation about associated diseases and biological pathways
are also stored when available. While the identifiers serve
as links to external databases and web pages, the annota-
tions stored within PARPs-DB are human readable and
easily searchable. PARPs-DB also supports input of local
protein sequences and annotations, as well as pointers to
local databases. A sequence or annotation marked as
"defunct" will not automatically be deleted from the data-
base, which means old FASTA files can be reanalysed with
new annotations even if their records have been deleted or
replaced by subsequent information in the primary
source.
The database was designed to contain a minimal amount
of information but still sufficient data to allow effective
Structured Query Language (SQL) queries. These queries
enable ready access to any information stored in the data-
base as well as in the XML files generated by the data anal-
ysis server. With the tables and XML files serving as the
primary data storage objects, the relational dataset is rela-
tively easy to build, maintain and query.
LC-MS/MS data analytical module
A key design element of PARPs database is the ability to
generate analytic modules that plug into and use the core
of PARPs system. Three pivotal LC-MS/MS tools inte-
grated in PARPs-DB are the peptide-spectrum matching
programs: Sequest, X!Tandem and Mascot. We have also
included PeptideProphet to validate peptides assigned to
MS/MS spectra [28] and ProteinProphet to infer the pro-
teins[29] present in the sample from the list of observed
peptides. These open-source tools are components of the
Trans Proteomic Pipeline (TPP) from Seattle Institute for
Systems Biology (ISB) [30]. To access MS/MS data, RAW
files were converted to the open file format (mzXML or
mzData) using Readw.exe from Sashimi for LTQ mass
spectrometer for example or our own conversion soft-
ware. Sashimi [22]is a project initiated at the ISB that aims
at providing the scientific community with free and open-
source software tools for the downstream analysis of mass
spectrometric data. Sashimi is focused on the bioinfor-
matics standards necessary to the set up of a generic pro-
teomic pipeline using common output formats at each
processing step. We have also integrated three executable:
Sequest2XML, Mascot2XML and Tandem2XML, also from
Sashimi, to convert search engine outputs (DAT, OUT and
XML files) to pepXML[31].
Links to public databases
The underlying protein knowledge base used by PARPs-
DB was extracted from multiple online resources, based
on cross-references. Five human gene and protein data
sources were integrated within PARPs-DB : protein data-BMC Bioinformatics 2007, 8:483 http://www.biomedcentral.com/1471-2105/8/483
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bases maintained by IPI [32] and UniProt [33], and three
NCBI databases: Entrez Gene [34], RefSeq [35], and Gen-
Pept. Three protein-protein interactions databases were
also included in PARPs-DB's knowledge base : the Biomo-
lecular Interaction Network Database (BIND)[36], the
Database of Interacting Proteins (DIP)[37] and Human
Protein Reference Database (HPRD) [38]. For each identi-
fied protein stored in PARPs-DB, the data analysis server
gathers the protein's function, sequence and post-transla-
tional modifications from the above sources and presents
the extracted data along with the identified protein. Dif-
ferent strategies have been used to update our databases.
For protein databases such as Uniprot and IPI, we use Perl
scripts to download Fasta files from the Uniprot and EBI
server. A report of the new release updates is produced.
For protein-protein interaction databases such as HPRD
and BIND, monthly updates are also performed through
Perl scripts.
Protein-Protein interaction viewer
Finally, in order to visualize protein-protein interaction
networks, we have developed a protein-protein interac-
tion viewer, in Java language (Java JDK 1.4.2_05 and Net-
beans 3.6). This viewer uses three libraries: Xerces Java
Parser 2.6.2, Piccolo Java 1.1, and JDOM 1.0 this last
library being used to manipulate and parse the XML files.
The central organization of the protein-protein interac-
tion viewer is a network graph with molecular species rep-
resented as nodes and intermolecular interactions
represented as links, that is, edges between nodes. This
application provides basic functionality for integrating
data on the graph, a visual representation of the graph and
integrated data. Data are integrated with the graph model
using attributes. Graphical browsers allow the user to
examine all attributes on the currently selected nodes and
edges.
One of the most fundamental tools for interpreting
molecular interaction data is visualization of nodes and
edge as two dimensional network. It utilizes a relaxation
layout algorithm which attempts to prevent overlapping
of nodes. This viewer is small, stable, multi-platform and
simple to use. It can function as a stand-alone applet or be
integrated into a web application.
PARP-1 co-immunoprecipitation
Cell culture
Human cervical carcinoma HeLa cells obtained from
ATCC (Manassas, VA, USA) were cultured in Dulbecco's
modified Eagle's medium (DMEM) supplemented with
10% fetal bovine serum, 2 mM L-glutamine, 100 U/ml
penicillin and 100 μg/ml streptomycin in an humidified
atmosphere of 5% CO2 at 37°C. All the above-mentioned
reagents were purchased from Invitrogen (Burlington,
ON, Canada).
Immunoprecipitation of endogeneous PARP-1
Cells grown in 150 mm culture dishes were washed with
ice-cold phosphate-buffered saline (PBS). 400 μl/dish of
ice-cold lysis buffer (175 mM KPO4, pH 8.0, 150 mM
NaCl, 1% NP-40, 1 mM DTT, 0.5 mM PMSF and Com-
plete™ protease-inhibitor cocktail (according to Roche
diagnostics instructions)) was added to the cells. Cells
were harvested using a cell scraper. Lysed cells coming
from three dishes were pooled then gently mixed by inver-
sion for 1 hour at 4°C and centrifuged 10 minutes at 6000
g at 4°C to remove insoluble cellular debris. The cellular
extract was mixed with 180 μl of magnetic beads coupled
to protein G (Dynal, Invitrogen) and 8 μl of monoclonal
antibody to PARP-1(F1-23)or 8 μl of normal mouse IgG
as control and incubated during 2 hours at 4°C with rota-
tion. The beads had been previously blocked during 1
hour with 1% BSA and washed with lysis buffer. At the
end of the incubation period, the beads were washed 3
times with lysis buffer. 180 μl of 2× Laemmli SDS sample
buffer containing 5% (v/v) β-mercaptoethanol was added
to the beads and they were placed in a boiling bath for 5
minutes to elute the immunoprecipitated proteins.
Protein separation and digestion
Immunoprecipitated proteins were separated by SDS 8%
PAGE. The gel was fixed for 30 min with 10% (v/v) meth-
anol and 7% (v/v) acetic acid solution, then stained with
SYPRO Ruby fluorescent protein stain (Bio-Rad, Hercules,
CA, USA) according to the manufacturer's instruction. The
entire protein profile of the immunoprecipitated proteins
was sliced from the gel into 50 bands using a gel excision
Lanepicker™ (The Gel Company) and placed into a 96-
well plate. In-gel protein digests were performed on a
MassPrep™ liquid handling station (Waters) using
sequencing-grade modified trypsin (Promega) according
to the manufacturer's instructions. Peptide extracts were
evaporated to dryness using a SpeedVac™ and resus-
pended in 10 μl of 0.1% formic acid in water.
LC-MS/MS
Final extracts were analysed by LC-MS/MS using an LCQ-
DECA XP mass spectrometer equipped with a nanospray
ESI (electrospray ionization) source and a Surveyor
autosampler and HPLC system (Thermo Electron). A 5 μl
volume of extract was first focused on a Peptide CapTrap™
(Michrom Bioresources) and then loaded on a Biobasic
C18  PicoFRIT™capillary column (PFC7515-BI-10; New
Objective). Elution of peptides was performed using a lin-
ear acetonitrile gradient (0–60%) over 20 min at a flow
rate of approximately 200 nl/min (buffer A: 0.1% formic
acid in water; buffer B: 0.1% formic acid in acetonitrile).
MS, including collision-induced dissociation, was per-
formed in an automated fashion using the dynamic exclu-
sion option.BMC Bioinformatics 2007, 8:483 http://www.biomedcentral.com/1471-2105/8/483
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Protein identification
Peptides were assigned MS/MS spectra by searching using
Sequest (version 2.0 SR2), Mascot (version 2.1) and
X!Tandem (2006.04.01.2) and the assignments were also
validated with Scaffold software (Proteome Software Inc.;
version Scaffold-01_03_02). MS/MS spectra were
searched against the IPI human protein database (version
3.01)[32] to which the sequences of protein constructs,
proteins of interest, and common contaminants were
added. Searches were performed specifying complete
(fixed) carbamidomethylation modification of cysteine
(+57 Da) and oxidation of methionine (+16 Da) residues.
The digestion enzyme parameter was set to trypsin. The
proteins identified in this paper were obtained with a
Scaffold probability cut-off of 80%.
Western blots
Total protein extracts and proteins eluted from the immu-
noprecipitations were separated by 8% SDS-PAGE and
then transferred onto a 0.45 μm pore-size PVDF mem-
brane (Millipore, Bedford, MA, USA). After incubating 1
hour with the blocking solution (PBS with 0.1% (v/v)
Tween-20 (PBS-T) containing 5% non-fat milk), the
membrane was probed with primary antibodies to PARP1
(C2-10, mouse monoclonal 1:5000) or RFC1 (Replication
factor C, 140 kDa subunit, rabbit polyclonal antibody
1:2500) (Bethyl Laboratories, Montgomery, TX, USA)
overnight at room temperature with shaking. After wash-
ing with PBS-T, species-specific horseradish peroxidase-
conjugated secondary antibody was added for 1 hour at
room temperature. The signals were finally detected with
the Western Lightning™ Chemiluminescence reagent plus
kit (Perkin Elmer, Boston, MA, USA).
Utility and Discussion
Protein interaction research workflow
The workflow of the PARPs protein interaction research is
illustrated in Figure 2. In our LIMS, the data processing is
divided into sections corresponding to the four main
steps: sample preparation, MS Data acquisition, protein
identification, and PARPs-DB.
The sample preparation (Figure 2A) section allows laborato-
ries to track and organize biological experiments and view
the workflow of those experiments.
For the purpose of MS data acquisition (Figure 2B), differ-
ent types of mass spectrometers, using different methods
for ionization and mass determination, may be used. As
the instruments from diverse suppliers use different for-
mats to store instrument parameters and spectral data,
PARPs-DB uses parsers to convert the data from the differ-
ent mass spectrometers (LTQ and QSTAR) into mzXML/
mzData. PARPs-DB is very flexible. Additional mass spec-
trometers and converters to XML files can be easily
included. mzXML and mzData are designed to encompass
all of the information required by the peptide-spectrum
matching software such as Sequest and Mascot. Moreover
these data representations, developed respectively by Seat-
tle Institute for Systems Biology (ISB) and the European
Bioinformatics Institute (EBI), provide an OS and archi-
tecture-independent standardized file format and remove
the burden of having to support multiple native formats.
The Sashimi project currently provides converters from
native binary files to mzXML (example ReAdW, convert
the RAW files generated by Xcalibur). Unfortunately, there
is no program available to convert proprietary binary for-
mat to mzData. Therefore, the easiest way to publish a
peak list data in mzData today is to convert mzXML into
mzData using any XML parser.
By converting all native binary data to mzXML/mzData
and using these standards at the start of our analysis pipe-
line, the downstream software tools, specifically the data-
base search module and raw spectral viewer, can be used
in a uniform manner regardless of the instrument used to
acquire the MS/MS spectra.
Schematic overview of the approach for PARPs protein inter- action research Figure 2
Schematic overview of the approach for PARPs pro-
tein interaction research. The steps are (A) PARPs co-
immunoprecipitation and with interactors; (B) generation of 
mass spectral data; (C) peptide sequence assignments using 
different search engines and protein identifications using dif-
ferent methods of inference; (D) the annotations and results 
are loaded automatically into PARPs database for viewing, 
annotation and analyses.BMC Bioinformatics 2007, 8:483 http://www.biomedcentral.com/1471-2105/8/483
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In order to identify proteins from the tandem mass (MS/
MS) spectra, the protein identification section (Figure 2C) is
used to submit the spectra to three search engines, namely
Sequest, Mascot and X!Tandem. PARPs-DB MS/MS ana-
lytical module stores, shares, analyses, mines and pub-
lishes tandem MS data. This module supports pepXML,
which stores the results of peptide sequence assignments
and subsequent peptide-level analyses in a XML files. After
search results have been written or converted to pepXML,
they can uniformly be subjected to peptide-level applica-
tions and viewed without regard to the algorithm used to
assign peptides to MS/MS spectra. Users can examine indi-
vidual LC-MS/MS runs and groups of runs using complex
customizable analytical filters for peptides and proteins
on the various search engine specific scores (XCorr for
Sequest, log(e) for X!Tandem). These filters can be saved
for later use. Finally, protein identifications are stored in
protXML. The multiple possibility discordant sequence
identification presented in each run is encompassed by
protein ProteinProphet which all peptide evidence is
combined. This data in XML format (developed by Sash-
imi) stores protein identifications inferred from input lists
of peptides and their subsequent protein-level analyses.
After protein identifications are converted to protXML,
protein-level analyses such as protein quantification can
proceed and results viewed without regard to the method
used to infer protein identification. With the help of this
standard, we have used a set of open source tools, Pepti-
deProphet and ProteinProphet, which provide a standard-
ized method of validating MS/MS data. For example,
accurate probabilities provided by PeptideProphet and
ProteinProphet serve as guides for the interpretation of
peptide and protein identifications, respectively, and ena-
ble the prediction of false positive error rates that can be
used as objective criteria for the comparison of data sets
generated by different researchers. This module interacts
with the protein annotation (described in the next sec-
tion) module to display information rich annotations for
putative protein identifications.
This last section represents the PARPs database (Figure
2D). Following the execution of the data processing meth-
ods described above, the results are loaded automatically
into PARPs-DB for viewing. The database system is inter-
connected with the protein annotation module (Figure
2D). This module manages protein sequence annotations
to help investigators cope with any newly updated or
revised information about proteins and their properties.
Sequence annotations are automatically updated. How-
ever, updates to the system are stored incrementally so
that any previous version of a database annotation can be
retrieved at any time. Protein annotations interact closely
with the protein identification section to allow users to
view up-to-date descriptions of protein sequence that
have been identified.
A sequence or annotation marked as "defunct" will not
automatically be deleted from the database, which means
old FASTA files can be reanalyzed with new annotations
even if their records have been deleted or replaced by sub-
sequent information in the primary source. Specific data-
bases such as UniProt, IPI, RefSeq, BIND, HPRD, Gene
Ontology are downloaded in the PARPs-DB.
Accessing and navigating experiments in PARPs database
To facilitate data analysis, a graphical user interface (GUI)
was developed. The GUI guides the user through all steps
of the experiment to enter information such as immuno-
precipitation methods, gel images, mass spectra, search
engine results, etc. (Figure 3), which ensure a complete
documentation of the experimental setting. After all nec-
essary data have been stored in the system, the user can
select data sets for visualization.
To access the LIMS server using a web-based client, the
user must first login with an authorized username and a
given password. PARPs-DB users are authenticated against
a  Lightweight Directory Access Protocol (LDAP) pro-
vider such as institution's name server. Experimental data
and other materials are stored in projects and their sub-
folders, much like a file system. Each project has one or
more groups of users associated with it, and each group
can have a distinct set of permissions (e.g., read only, read
and write) to each of the project's folder. When users log
in, the authorization system determines what data they
have permission to view, edit, and/or delete and provides
access accordingly.
Inside the PARPs-DB, there are three main sections, "sam-
ple origin," "mass spectrometry" and "sample results" corre-
sponding to different steps of a proteomic experiment.
These sections allow users to store experimental parame-
ters, results and annotations. Each section has a distinct
set of permissions. For example, a molecular biologist
cannot access the mass spectrometry section, and con-
versely, mass spectrometer users cannot access the molec-
ular biology section. In each section, we have developed
tools to help the user reduce the time needed to analyse
data.
First, the sample origin section enables the user to enter
experimental parameters by selecting a number of
options. Experimental information includes cell type and
cellular conditions, method of gene transfer (when appli-
cable) and gene sequence, and details of the immunopre-
cipitation method such as lysis buffer composition,
antibodies, cell lysis. The user can print experimental
details entered in the database (Figure 3A). For example,
an image of a stained gel showing proteins immunopre-
cipitated in the described experiment may be loaded into
the database.BMC Bioinformatics 2007, 8:483 http://www.biomedcentral.com/1471-2105/8/483
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PARPs database user interfaces Figure 3
PARPs database user interfaces. (A) In the Sample Origin section the user can enter experimental parameters and visual-
ize the experimental protocol; (B) In the Mass Spectrometry section the user defines the parameters of the mass spectrome-
ter; IPxxx is the identification of immunoprecipitation experience. (C) The Protein Identification section summarizes protein 
identifications, including protein accession number, entrez gene accession, number of peptides identified and a protein sum-
mary function; (D) The Protein Card Layout contains links to a variety of external public sources; (E) The Protein-Protein 
Interaction Viewer allows the user to display protein-protein interactions from internal and external (publicly available) data 
sources. The full-scale schema is available on-line as supplemental Figure.BMC Bioinformatics 2007, 8:483 http://www.biomedcentral.com/1471-2105/8/483
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The second section of PARPs-DB is the mass spectrometry
section. In this section, the user may define the parameters
of a mass spectrometry experiment including: the plate
number, the spot position, method files (Figure 3B) and
parameters for search engines. A tabular file is generated
to upload the list of samples into the mass spectrometer
software. At the end of MS/MS analysis, the raw data is
transformed in mzXML and mzData automatically in the
background. Unfortunately, all converters run on win-
dows environment because some Windows specific librar-
ies are necessary. After each run, the binary data files are
transformed locally in XML files on windows computer.
After the conversion, each XML files are transferred with
Secure File Transfert Protocol (SFTP) to UNIX server.
The user accesses database searching through another sec-
tion of the user interface in order to set specific search
engine parameters such as the database to be searched and
amino acid modifications. The data pipeline will submit
the mzXML or mzData to the search algorithms and man-
age the specification of search parameters and FASTA files.
Once analysed, the system offers graphical and tabular
views of the experimental steps and their input and out-
put. Users can monitor the progress of their searches via
the web interface.
The last section of PARPs-DB is the sample results section.
Access to LC-MS/MS results is available in this section,
which shows protein and peptide identifications in the list
view of the PARPs database. The data may be sorted
according to certain experimental protocols (e.g. diges-
tion) or according to the identification probabilities (Fig-
ure 3C). Display columns include the UniProt[33] or
IPI[32] or RefSeq [35] annotation, the number of
uniquely identified peptides per protein, and the total
number of identified peptides per protein. MS/MS search
results can be evaluated using this module, which allows
proteins and peptides to be sorted and filtered by various
criteria. Each identified protein is linked to the protein
annotation module (see below), through which it is auto-
matically linked following parsing of the FASTA file,
allowing access to a variety of up-to-date external sources
(Figure 3D). The accession numbers of proteins identified
from the Sequest, X!Tandem, or Mascot searches are
matched with those from IPI, and specific information
regarding the protein of interest is automatically retrieved
and displayed within the database window. Additional
information from the software-assisted identification of
the protein is displayed in a portal view, including identi-
fied peptides. The purpose of this feature of the PARPs
database is to automatically connect protein identifica-
tions to their function and other relevant biological infor-
mation extracted from external databases. A statistics
module within PARPs-DB provides basic information
about each experiment in the form of charts (e.g. gene
ontology annotations, the number of peptides per pro-
tein, proteins identified with a certain ProteinProphet
probability, etc.). In addition, the database allows for the
comparison of data from different experiments at protein
and peptide levels. Users are able to query the database,
add notes to specific identifications, and select and export
lists of interesting proteins including annotations.
Different tools are accessible throughout PARPs database
navigation. These include BLAST, CLUSTALW and our
protein-protein interaction viewer, a graphical tool that is
linked to PARPs-DB. The viewer displays protein-protein
interactions from the PARPs-DB (Figure 3E). The protein
interaction network is shown as nodes (proteins) and
edges (interactions). The interaction network can also be
displayed with the annotations for the proteins in the
nodes. Each node is linked to the protein annotation
module. We displayed the confidence of each external
protein-protein interaction using the thickness of the edge
(default value 2). Redundant interactions independent
reports in each external data source were assigned confi-
dence values of 3. In addition, the colour (red: Bind data-
base, blue: HPRD database, or green: PARPs database) of
the edges can be selected to indicate the respective data
sources.
The user can scan all the deposited internal (our protein-
protein interaction assays) and external protein-protein
interactions (from publicly available data sources:
INTACT, BIND, HPRD, String) in the database. Informa-
tion about protein-protein interactions beyond the target
protein is shown in the interaction network to visually
characterize the protein network. Proteins of interest can
be searched by either accession number or keywords.
When users input the accession number of a protein, the
protein interaction network is shown as nodes (proteins)
and edges (interactions). The interaction network can also
be displayed with the annotations for the proteins in the
nodes. Each node is linked to the protein annotation.
Data and results can be exported to other formats includ-
ing PSI-MI, Excel and DTA (Sequest files) for additional
analysis using other tools. This method was created to
exchange data easily between different laboratories.
Using proteomics standards in PARPs database
A major obstacle to uniform proteomic analysis has been
the great heterogeneity of data formats at three distinct
levels: different mass spectrometers output their raw spec-
tral data in different proprietary formats, methods that
assign peptides to MS/MS spectra output their results in a
variety of formats, and different methods to infer protein
identifications from lists of peptides output their results in
different formats. The proteomics community has recog-
nized this problem and is tackling it through the forma-
tion of working groups (Proteomics Standard Initiative;BMC Bioinformatics 2007, 8:483 http://www.biomedcentral.com/1471-2105/8/483
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Institute for Systems biology) concerned with the devel-
opment of standards for the capture and sharing of pro-
teomics data. The PARPs database was developed in
agreement with the HUPO-PSI (Human Proteome Organ-
ization-Proteomics Standard Initiative), which includes
PSI-MI (Molecular Interactions), MS (Mass spectrometry)
and GPS (General Proteomics Standards). The GPS devel-
opment of standard ways to represent proteomics data
and an agreed minimum required level of detail are both
urgently required to facilitate the analysis, dissemination
and exchange of proteomics data. Minimal Information
about Proteomic Experiment (MIAPE) is a proposed
standard format for proteomics covering 2-DE and MS.
The PARPs database contains classes derived from
PEDRo[13]. As mentioned earlier, the latest proteomic
standards such as mzXML, mzData and PSI-MI have been
incorporated into our pipeline. We expect the new format
such as mzXML to facilitate the exchange and publication
of MS-based proteomics data and that our PARPs database
will provide a consistent platform for the development of
new analytical tools.
We have developed PARPs-DB as an in-house, flexible
Laboratory Information Management System (LIMS)
which integrates all aspects of the study of protein-protein
interactions by mass spectrometry-based proteomics,
from sample processing information to protein interac-
tions visualization. PARPs-DB allows easy network access
to public databases, manages the output of different
search engines (MASCOT, X!Tandem and Sequest) and
The biochemical and physical protein interaction network for PARP-1 Figure 4
The biochemical and physical protein interaction network for PARP-1. This figure is a summary of the results of the 
protein-protein interaction databases and literature searches for PARP-1 substrates and cooperators. This figure is a hand-
drawn representation from the interaction viewer.BMC Bioinformatics 2007, 8:483 http://www.biomedcentral.com/1471-2105/8/483
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supports HUPO's Proteomic Standard Initiative formats.
Although several LIMS have been made freely available
during last few years, none of these existed when work on
the PARPs database was initiated in 2002. Advantages of
PARPs-DB over these free LIMS includes: integration of all
data related to the mass spectrometry-based study of pro-
tein-protein interactions; multiple search engine support;
and user-friendliness.
It is indicative of the poor availability of appropriate com-
mercial systems that development of in-house LIMS such
as PARPs-DB started at around the same time in different
laboratories across the world, in order to fill the urgent
need to automate proteomic data storage and analysis.
Commercial LIMS now available remain however prohib-
itively expensive for small MS facilities and more rigid
than an in-house system. These systems often include rig-
orously defined user roles and access privileges, as well as
extensive auditing of data file changes. Although essential
to pharmaceutical companies filing drug applications
which must comply to regulatory standards (e.g. 21 CFR
part 11), these features can hamper academic research
because files can not easily be modified, maintained, and
updated. Additionally, integration of the output of a new
mass spectrometer can be more difficult and costly than
with an in-house, flexible system. Finally, available LIMS
from mass spectrometer vendors present many limita-
tions: there is notably no integration of the data generated
by other vendors' instruments, nor of the data not directly
to the mass spectrometer; for instance, they do not handle
pre-MS sample processing information and protein inter-
action data.
Constructing protein-protein interaction network for 
PARP-1
To illustrate the use of PARPs-DB for discovery of protein-
protein interactions, we describe here an experiment for
PARP-1 co-immunoprecipitation with interacting pro-
teins. This co-immunoprecipitation is part of experi-
ments aiming at identifying PARP-1 interactors which
will be published elsewhere (Ethier et al., manuscript in
preparation). Construction of this interaction network
involved three bioinformatics steps and the predicted
interactions were then verified using standard biochemi-
cal techniques.
Step1. Identification of PARP-1 interacting proteins from published 
experimental studies
The first step in the generation of PARP-1 interaction model
is an extensive search of the literature in order to collect
published experimental data on PARP-1 interactions. The
keyword used in the PARPs-DB search for literature was
PARP-1. However, a functional network is not only limited
to physical protein-protein interactions but also includes
genetic and biochemical interactions (Figure 4).
Step2. Establishment of the PARP-1 interaction network by analysis 
of public databases
The interacting molecules are summarized in Figure 4.
Four different comprehensive large-scale yeast protein
interaction databases were included in PARPs-DB: BIND,
HPRD, INTACT, and STRING. Search within these data-
bases resulted in 52 PARP-1 interactors. BIND, INTACT,
HPRD and STRING all have extensive collections of
human protein-protein interactions, although the former
three databases are primarily used to extract, but not pre-
dict, protein-protein interaction data from literature. The
database STRING ('Search Tool for the Retrieval of Inter-
acting Genes/Proteins') aims to collect, predict and unify
most types of protein-protein associations, including
PARP-1 protein interactions involved in DNA replication Figure 5
PARP-1 protein interactions involved in DNA repli-
cation. In silico prediction from the protein-protein interac-
tion databases of proteins with a specific function in the 
replication machinery. To provide maximal coverage of the 
potential interactome, results from four databases were 
compiled. These comprehensive database analyses revealed 
52 proteins as potential interaction candidates with PARP-
1(figure 4). These candidate proteins were further prioritized 
using searches based on two Gene Ontology keywords 
(DNA and replication), and 13 proteins were selected on the 
basis of their unique molecular functions. Further literature 
reviews identified the proteins in the DNA replication com-
plex, Replication Factor Complex (RFC) complex. Proliferat-
ing Cell Nuclear Antigen (PCNA) has been shown to interact 
biochemically and/or genetically with PARP-1. In this way the 
potential interactions between PARP-1 and RFC1, 2, 3, 4, 5 
was discovered. The solid lines represent direct protein 
interactions, and the dashed lines represent proteins found in 
a protein complex. The colour code is described in figure 4.BMC Bioinformatics 2007, 8:483 http://www.biomedcentral.com/1471-2105/8/483
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direct and indirect associations. In order to cover organ-
isms not yet addressed experimentally, STRING runs a set
of prediction algorithms, and transfers known interac-
tions from model organisms to other species based on
predicted orthology of the respective proteins.
One important point in the analysis of data from public
protein-protein interaction databases is the quality of the
results. Indeed, Deng et al compared the data from all the
large-scale yeast interactions screens present in the public
protein interaction databases. They developed a maxi-
mum likelihood estimation method to access the reliabil-
ity of the interaction data, and found that the Uetzdata
were more reliable than the Ito[8] data, and that the Gavin
data were more reliable than the Ho data. Therefore, a
cautious use of public databases is indicated. In addition,
they suggested that the MS-based analysis of protein com-
plexes performed better in function predictions than the
two-hybrid data, thus validating the theory that each com-
ponent of a complex can be assigned a function based on
that of the whole complex. It is clear that yeast two-hybrid
and MS-based techniques have both independently made
significant impacts on our understanding of the interac-
tome. However, each technique has specific drawbacks
that limit the information provided if used alone.
Step3. Selection of Protein-Protein Interaction by Gene Ontology 
Accession
The next step was to group protein-protein interactions by
molecular function via the Gene Ontology [27] controlled
vocabulary included in PARPs-DB. Because intracellular
events may be compartmentalized to unique intracellular
location, to provide additional specificity for target selection
we also included a spatial component to further refine the
construction of the model. Therefore, we further prioritized
our target selection by using two keywords (DNA replication
and nucleus). We chose these two keywords to illustrate our
approach but PARP-1 is involved in many other cellular
processes. After filtering according to function, six out of the
52 initial proteins interactors remained in the networks:
PCNA, topoisomerase I and II, DNA ligase I, DNA Pol α and
β. An extensive literature search about these proteins in the
context of replication and data mining helped to construct a
human PARP-1-protein interaction map in PARPs-DB. We
found 13 proteins and one complex that interact with PARP-
1 in the complex machinery replication. Of the 13 interact-
ing proteins, PCNA, topoisomerase I, DNA ligase I, DNA Pol
α and β have been previously reported to interact with PARP-
1. Topo2, MSH2, RFC1, RFC2, RFC3, RFC4, RFC5 have been
reported to be related to DNA replication. This analysis raises
the possibility that PARP-1 may regulate these complexes as
a whole rather than regulate one or more the individual
components. Of all the potential candidates, we propose
that PARP-1 could interact with other proteins in RFC (RFC1
to RFC5) in the context of machinery replication (Figure 5).
Demonstration of biochemical interactions between PARP-1 and 
RFC1
Verifying the interactions from molecules identified in sil-
ico is vital to provide a confident interaction network use-
ful for further study. With the exception of PCNA, which
has been characterized, the prioritized candidates were
next tested experimentally to confirm the predicted pro-
tein-protein interactions. This was carried out using co-
immunoprecipitation of PARP-1 followed by mass spec-
trometry to identify the interacting proteins.
Scaffold (version Scaffold-01_03_02) was used to group
and validate MS/MS based peptide and protein identifica-
tions from Sequest, Mascot and X!Tandem. This software
is based on the PeptideProphet algorithm which provides
an empirical statistical model which estimates the accu-
racy of peptide identifications made by database search
engines. For each tandem mass spectrum, PeptideProphet
determines the probability that the spectrum is correctly
assigned to a peptide. Scaffold system was used to group
the assigned peptides according to corresponding protein
and to compute probability of a correct protein assign-
ment for each protein. Peptide identifications with Scaf-
fold software were accepted if they could be established at
greater than 80.0% probability as specified by the Peptide-
Prophet algorithm. For the co-immunoprecipitation elu-
ate, protein identifications were accepted if they could be
established at greater than 95% probability and contained
at least 2 identified peptides. Table 1 lists all the RFC pro-
teins identified with a minimum probability of 95%. It
should be noted that the maximal protein probability is
limited to 95% in Scaffold. This was set to take into
account the light risk that a peptide spectrum match
PARP-1 and the interactor RFC1 were immunoprecipitated  with mouse monoclonal F1-23 antibody. RFC1 was detected  by western blot with a rabbit polyclonal RFC1 antibody Figure 6
PARP-1 and the interactor RFC1 were immunopre-
cipitated with mouse monoclonal F1-23 antibody. 
RFC1 was detected by western blot with a rabbit pol-
yclonal RFC1 antibody. PARP-1 was detected by western 
blot with the mouse monoclonal C2-10 antibody. Ctr : 
Immunoprecipitation was done with normal mouse IgG 
instead of F1-23 antibody.
PARP-1 113 kDa
Ctr Ctr F1-23 F1-23
Total lysate IP
WB MW
RFC1 140 kDaBMC Bioinformatics 2007, 8:483 http://www.biomedcentral.com/1471-2105/8/483
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(PSM) is incorrect even if the theoretical and experimental
spectra are very similar (e.g: correct peptide absent from
the search database).
The co-immunoprecipitation assay with RFC1 antibody
performed in HeLa cells suggests that Replication Factor C
subunit (RFC1, 2, 3, 4, 5) (Table 1 and Table 2) formed a
complex with endogenous PARP-1. The protein sequence
coverage of PARP-1 in this study is 60%.
RFC-2, 3, 4 and 5 were each identified with a minimum
probability of 95% and by more than 4 peptides with a
minimum probability of 95%. The confidence of the
identification of RFC-2, 3, 4 and 5 is thus very high and,
moreover, we have identified this RFC complex in several
co-immunoprecipitates. The case of RFC-1 is different as it
was identified by only two peptides of probabilities of
95% and identified in only one co-immunoprecipitate.
For this reason, this potential interaction was confirmed
by western blot analysis of complexes immunopurified
with mouse monoclonal F1-23 antibody (Figure 6). RFC-
1 was detected by western blot analysis with rabbit poly-
clonal RFC1 antibody. As expected, RFC-1 was pulled-
down by PARP-1. Although substantially more work is
required to determine whether RFC complex interacts
directly with PARP-1 or via other proteins such as PCNA,
DNA polymerase or through interaction with poly(ADP-
ribose), the findings reported here suggest that the PARPs-
DB may be useful for finding interacting proteins.
Table 1: List of peptides of RFC-1-5. List of peptides of RFC1-5 subunits identified in an immunoprecipitation of PARP-1 from a HeLa 
cell lysate by LC MS/MS to the experiment number assigned by the PARPs-DB. This table summarizes the identification from 5 
independent immunoprecipitation experiments.
IPI SwissProt Protein identification Gene name Peptide probability
IPI00375358 P35251 Splice Isoform 1 of Activator 1 140 kDa subunit RFC1
AALLSGPPGVGK 95,00%
AIVAESLNNTSIK 95,00%





























TSTILACAK 95,00%BMC Bioinformatics 2007, 8:483 http://www.biomedcentral.com/1471-2105/8/483
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Conclusion
The work presented here has demonstrated how bioinfor-
matics can supplement conventional biological investiga-
tion. The PARPs-DB enables storage, annotation and
representation of data generated by molecular biology.
Moreover this system has identified a previously
unknown protein interaction of PARP-1. The PARPs data-
base allows the effective description of proteomics exper-
iments and analysis of protein-protein interactions.
Because the PARPs database was developed to facilitate
data sharing and exchange, it includes the latest standard
format to allow sharing of experimental design and results
with the scientific community. We have incorporated
tools allowing the extraction of protein-protein interac-
tions from the HPRD, DIP and BIND public databases, lit-
erature and other sources of information. Reports for
peptide and protein analyses are output. These provide
comparison reports from multiple or concatenated exper-
iments, thereby significantly increasing the confidence in
peptide and protein identifications.
The biochemical data between PARP-1 and RFC complex
confirmed the interaction reported earlier. However, sub-
stantially more work is required to delineate the specifi-
city and the structural interaction with respect to the
regulation of their cellular function between PARP-1 and
RFC complex. It is anticipated that the building of such an
integrated platform, which can be constantly up-graded,
could provide a predictive understanding of a novel gene's
function in its biological context. A key design element of
PARPs database is the ability to add tools or module that
plug into and use the core systems. The PARPs-DB will be




Project home page: http://sourceforge.net/projects/
parpdb/
Operating system(s) : Unix, Linux, Oracle and MySQL;
Programming Language: Perl, JAVA, SQL;
Licence: GNU GPL;
PARPs-DB is distributed under the GNU GPL licence and
available from the website http://sourceforge.net/
projects/parpdb/
Abbreviations
SQL: Standard Query Language; NCBI: National Center
for Biotechnology Information; MS: Mass spectrometry;
PARP: Poly(ADP-Ribose) Polymerase; ISB: Institute for
Systems Biology; EBI: European Bioinformatics Institute;
LDAP: Lightweight Directory Access Protocol; IPI: Interna-
tional Protein Index; HPRD: Human Protein Reference
Database; BIND: Biology Interaction Database.
Table 2: List of proteins found. List of proteins found with Sequest and X!Tandem from the PARP-1 immunoprecipitation assay and 
validated with Scaffold software. Biological sample name refers to the experiment number assigned by the PARPs-DB. This table 













IP111 IPI00375358 P35251 Splice Isoform 1 of Activator 1 140 kDa subunit 99.8% RFC1
IP111 IPI00017412 P35250 Splice Isoform 1 of Activator 1 40 kDa subunit 92.9% RFC2
IP577 IPI00017412 P35250 Splice Isoform 1 of Activator 1 40 kDa subunit 100.0% RFC2
IP597 IPI00017412 P35250 Splice Isoform 1 of Activator 1 40 kDa subunit 100.0% RFC3
IP230 IPI00031521 P40938 Similar to human replication factor C (activator 1) 3, 38 kDa 87.7% RFC3
IP372 IPI00031521 P40938 Similar to human replication factor C (activator 1) 3, 38 kDa 99.8% RFC3
IP577 IPI00031521 P40938 Similar to human replication factor C (activator 1) 3, 38 kDa 100.0% RFC3
IP597 IPI00031521 P40938 Similar to human replication factor C (activator 1) 3, 38 kDa 100.0% RFC3
IP111 IPI00017381 P35249 Activator 1 37 kDa subunit 92.9% RFC4
IP577 IPI00017381 P35249 Activator 1 37 kDa subunit 100.0% RFC4
IP597 IPI00017381 P35249 Activator 1 37 kDa subunit 100.0% RFC4
IP577 IPI00031514 P40937 Activator 1 36 kDa subunit 100.0% RFC5
IP597 IPI00031514 P40937 Activator 1 36 kDa subunit 100.0% RFC5
IP111 IPI00449049 P09874 Poly [ADP-ribose] polymerase 1 100.0% PAPR-1
IP230 IPI00449049 P09874 Poly [ADP-ribose] polymerase 1 100.0% PARP-1
IP372 IPI00449049 P09874 Poly [ADP-ribose] polymerase 1 100.0% PARP-1
IP577 IPI00449049 P09874 Poly [ADP-ribose] polymerase 1 100.0% PARP-1
IP597 IPI00449049 P09874 Poly [ADP-ribose] polymerase 1 100.0% PAPR-1BMC Bioinformatics 2007, 8:483 http://www.biomedcentral.com/1471-2105/8/483
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